SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-107789
Filing Date
2020-09-23
Accepted
2020-09-23 15:56:02
Documents
1
Period of Report
2020-09-22

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3006
  Complete submission text file 0001104659-20-107789.txt   4471
Mailing Address 100 FEDERAL STREET 19TH FLOOR BOSTON MA 02110
Business Address 100 FEDERAL STREET 19TH FLOOR BOSTON MA 02110 6177728515
TEKLA LIFE SCIENCES INVESTORS (Issuer) CIK: 0000884121 (see all company filings)

IRS No.: 043147016 | State of Incorp.: MA | Fiscal Year End: 0930
SIC: 0000

Mailing Address KING PHARMACEUTICALS, INC. 501 FIFTH STREET BRISTOL TN 37620
Business Address
Bailey Jeffrey Allen (Reporting) CIK: 0001500210 (see all company filings)

Type: 4 | Act: 34 | File No.: 811-06565 | Film No.: 201192101